Clinical Trial Update: Central Nervous System Changes Following OnabotulinumtoxinA Injection in the Bladder

View source ↗

Summary

A completed clinical trial evaluating central nervous system changes after intravesical OnabotulinumtoxinA injections for bladder symptoms, with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Detrusor Overactivity
• Lower Urinary Tract Symptoms
• Multiple Sclerosis
• Neurogenic Bladder
• Urge Incontinence

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Multiple Sclerosis, Lower Urinary Tract Symptoms | Status: COMPLETED | Results posted: 2025-08-05